Dina Sparano, MD
Clinical Cardiac Electrophysiology · Mayfield Heights, OHNPI 1073769709
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $108,013 of the $146,814 with a category attached, or 73.6%. Boston Scientific accounts for 83.4% of it on its own, with 21 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 349 payments — averaging $420.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$122K
- Medtronic$20K
- Abbott$2K
- Biosense Webster, Inc.$596
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$355
- Atricure, Inc.$178
- plus $693 from 16 others
What the payments were for
- Consulting fees$108,01374%
- Speaking & faculty fees$21,60015%
- Travel & lodging$7,4785%
- Food & beverage$9,7247%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 129 | $122,410 |
| Medtronic(2 entities) | 119 | $20,283 |
| Abbott | 20 | $2,300 |
| Biosense Webster, Inc. | 16 | $596 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 28 | $355 |
| Atricure, Inc. | 3 | $178 |
| Impulse Dynamics (USA) Inc. | 1 | $133 |
| Johnson & Johnson | 7 | $117 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Novo Nordisk | 3 | $60 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Cardiva Medical, Inc. | 2 | $53 |
| Preventice Services, LLC | 3 | $32 |
| Abiomed | 1 | $28 |
| EKOS Corporation | 2 | $24 |
| Medical Device Business Services, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Shockwave Medical, Inc | 1 | $17 |
| Amgen | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLINICAL TRIAL PRODUCT$33,763
- GENERAL - THERAPIES$17,643
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$3,600
- Arctic Front$3,387
- EMBLEM MRI S-ICD$2,000
- Ensite Cardiac Mapping System$1,721
- Micra$1,585
- EVERA MRI XT DR SURESCAN$663
- S-ICD System Magnet$500
- Cobalt$400
- OPTIMIZER$267
- LINQ II$261
- Carto 3$227
- Evera$194
- TYRX$160
- Rhythmia Mapping System$154
- Claria MRI$147
- ARCTIC FRONT ADVANCE$146
- WATCHMAN Access System$135
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$119
How this compares
$146,814 in reported general payments places this provider in the 90th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 298 | $312,483 |
| XareltoRivaroxaban | 77 | $80,304 |
| Dofetilide | 68 | $12,613 |
| Flecainide Acetate | 101 | $4,075 |
| Amiodarone Hcl | 61 | $2,330 |
| Metoprolol Succinate | 155 | $2,218 |
| Digoxin | 20 | $1,859 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 20 | $644 |
| Metoprolol Tartrate | 100 | $567 |
| Atorvastatin Calcium | 27 | $407 |
| Losartan Potassium | 20 | $363 |
| Potassium Chloride | 20 | $226 |
| Furosemide | 48 | $190 |
| Amlodipine Besylate | 21 | $118 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $312,483298 claims |
| Johnson & JohnsonXarelto | $117 | $80,30477 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Mayfield Heights
- Anish AminColumbus$1.1M
- Walid SalibaCleveland$511K
- Mohamed KanjBeachwood$442K
- John HummelColumbus$275K
- Bruce WilkoffCleveland$213K
- Alexandru CosteaCincinnati$188K
- Auroa BadinColumbus$188K
- Gaurang GandhiCincinnati$179K
- Ralph AugostiniColumbus$174K
- Judith MackallCleveland$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.